1. Berchtold, P., Hillebrand, I., Boehme, K., Frank, G., Fink, H.: Effects of the glycosidehydrolase inhibitor BAY g 5421 on postprandial blood glucose-, serum insulin- and triglyceride levels in normal and overweight subjects. Diabetologia15, 218 (1978)
2. Berchtold, P., Kiesselbach, N.: Unpublished results from clinical trials conducted by Bayer (1976)
3. Bryce, G. R., Carter, M. W.: MAD—The analysis of variance in unbalanced designs—a software package. In: Compstat 1974, Proc. computational statistics, pp. 447–456. Wien: Physica Verlag 1974
4. Caspary, W. F.: Sucrose malabsorption in man after ingestion ofα-glucosidehydrolase inhibitor. Lancet1978 I, 1231–1233
5. Caspary, W. F., Graf, S.: Hemmung Kohlenhydrat-verdauender Enzyme aus menschlichem Dünndarm durch ein komplexes Oligosaccharid. 13. Kongress Dtsch. Diabetesgesellschaft Düsseldorf 1978 (abstract)